We present novel data demonstrating that the NTSR2–TrKB interaction and the sustained activation of the signaling pathways under the control of these two actors constitute an essential driving force for apoptosis evasion in B-CLL. This evidence concerns the gene NTRK2 and B-cell chronic lymphocytic leukemia.